{"nct_id":"NCT02018861","title":"A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101)","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2016-09-22","start_date_type":"ACTUAL","primary_completion_date":"2021-04-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["INCY"]}